Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a condensed version of the chemotherapy regimen
busulfan, melphalan, fludarabine (bu/mel/flu) and the drug antithymocyte globulin (ATG-also
referred to as rATG or thymoglobulin) can have the same or fewer number of severe side
effects in people with various blood cancers 30 days after they receive an allogeneic
hematopoietic cell transplantation.